BioAge Labs (BIOA) Enterprise Value (2023 - 2026)

BioAge Labs has disclosed Enterprise Value across 4 years of filings, most recently posting -$383.2 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$383.2 million, down 19.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$383.2 million (down 19.66% YoY), and the FY2025 annual result was -$281.1 million, up 20.67% from the prior year.
• Enterprise Value came in at -$383.2 million for Q1 2026 at BioAge Labs, down from -$281.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$25.0 million in Q4 2023 to a low of -$383.2 million in Q1 2026.
• The 4-year median for Enterprise Value is -$297.0 million (2025), against an average of -$272.8 million.
• Across the five-year window, Enterprise Value sank 1319.84% in 2024 and increased 20.67% in 2025, its largest moves.
• BioAge Labs' Enterprise Value stood at -$25.0 million in 2023, then tumbled by 1319.84% to -$354.3 million in 2024, then increased by 20.67% to -$281.1 million in 2025, then slumped by 36.32% to -$383.2 million in 2026.
• The last three Enterprise Value figures came in at -$383.2 million (Q1 2026), -$281.1 million (Q4 2025), and -$285.8 million (Q3 2025), per Business Quant data.